---
title: MSH2, MSH6, MLH1, and PMS2 immunohistochemistry as highly sensitive screening
  method for DNA mismatch repair deficiency syndromes in pediatric high-grade glioma
date: '2025-02-02'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39894875/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250203170930&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Pediatric high-grade glioma (pedHGG) can occur as first manifestation
  of cancer predisposition syndromes resulting from pathogenic germline variants in
  the DNA mismatch repair (MMR) genes MSH2, MSH6, MLH1, and PMS2. The aim of this
  study was to establish a generalized screening for Lynch syndrome and constitutional
  MMR deficiency (CMMRD) in pedHGG patients, as the detection of MMR deficiencies
  (MMRD) may enable the upfront therapeutic use of checkpoint inhibitors and identification
  of ...
disable_comments: true
---
Pediatric high-grade glioma (pedHGG) can occur as first manifestation of cancer predisposition syndromes resulting from pathogenic germline variants in the DNA mismatch repair (MMR) genes MSH2, MSH6, MLH1, and PMS2. The aim of this study was to establish a generalized screening for Lynch syndrome and constitutional MMR deficiency (CMMRD) in pedHGG patients, as the detection of MMR deficiencies (MMRD) may enable the upfront therapeutic use of checkpoint inhibitors and identification of ...